- Reported transaction lines
- 1
- Buy lines
- 1
- Sell lines
- 0
Filing activity by month
Original filing lines in up to 12 months with activity.
- 2026-111
Frequently disclosed stocks
Disclosure history
| Reporting investor | Security | Activity | Transaction / period | Filed | Reported amount | Source |
|---|---|---|---|---|---|---|
Joint filing · 2 reporting ownersOrchestra BioMed Holdings, Inc. | OBIO Orchestra BioMed Holdings, Inc. | BuyFiling detailsSEC transaction code P Common Stock · Indirect ownership · See footnote · Reported balance after transaction: 10756063 · SEC code covers open-market or private transactions · Held by certain affiliated funds (the "RTW Funds") managed by RTW Investments, LP ("RTW"). Roderick Wong, M.D. serves as the Managing Partner and Chief Investment Officer of RTW. The Reporting Persons disclaim beneficial ownership of the reported securities for purposes of Section 16 under the Securities Exchange Act of 1934, as amended, except to the extent of their respective pecuniary interests therein. | 2026-11-09 | 2026-11-12 | ≈ $6,000,000.00 1,200,000 shares/units | SEC 4 |
Counts describe original filing lines in BriefStock’s coverage. Later amendments can correct or supplement them. Check the original filing for ownership and transaction details.